Replies to post #5388 on Manhattan Scientifics Inc (MHTX)

[eatbytes]

On further reviewing of Dr. Deborah Jane Rhodes work at the Mayo Clinic, I suspect her work is a different technology unrelated to the Senior Scientifics technology. At least her work has been using her technology in actual clinical trails.

[ssc]

You're not implying this has anything to do with the MRX device that is still being debugged are you? MBI has been around for quite a while and recent human trials have shown great results with a much lower dose of radiation. It is designed to find tumors in dense breast tissue that mammograms have trouble identifying and is a completely different technology from Dr. Flynn's. On the other hand, Manhattan Scientifics' MRX technology has yet to reach the point where a request to the FDA to simply begin human studies is justified. It's great to see progress being made in this area; perhaps someday mhtx will be able to report something similar.

http://www.gammamedica.com/2015/01/breakthrough-mayo-clinic-study-confirms-molecular-breast-imaging-mbi-high-absolute-sensitivity-supplemental-low-dose-screening-studies-women-dense-breast-tissue/

Breakthrough Mayo Clinic Study Confirms Molecular Breast Imaging (MBI) High Absolute Sensitivity for Supplemental, Low-Dose Screening Studies in Women with Dense Breast Tissue